Latest news
Pacira BioSciences (PCRX) Is Down 7.1% After Advancing PCRX-201 Gene Therapy With Positive Phase 1 Data - simplywall.stsimplywall.st · Mon, 10 Aug 2026 12:35:09 GMTIs Pacira BioSciences (PCRX) Quietly Reframing Its Non‑Opioid Strategy Around PCRX‑201 Gene Therapy? - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 06:10:00 GMTState Street Corporation (NYSE: STT) discloses 5.2% ownership in Pacira BioSciences - Stock TitanStock Titan · Fri, 07 Aug 2026 14:33:48 GMTPress Release: Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - MoomooMoomoo · Fri, 07 Aug 2026 12:01:00 GMTPacira BioSciences, Inc. (PCRX) Stock forecasts - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 01:56:03 GMTPacira BioSciences (PCRX) Could Be 35% Undervalued On Phase 1 Gene Therapy Progress - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:14:02 GMTHere's What Analysts Are Forecasting For Pacira BioSciences, Inc. (NASDAQ:PCRX) After Its Second-Quarter Results - MoomooMoomoo · Thu, 06 Aug 2026 18:24:45 GMTOne knee injection study followed pain and function for 2 years - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMT